Prospective role of salivary MicroRNA for early detection - personalized therapy of head and neck squamous cell carcinoma

Oral Oncol. 2022 Nov:134:106063. doi: 10.1016/j.oraloncology.2022.106063. Epub 2022 Aug 11.

Authors

Saravanan Muthupandian¹, Manjusha Muralidharan¹, Yasasve Madhavan¹, N M Hariharan²

Affiliations

¹ AMR and Nanomedicine Laboratory, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, Tamil Nadu, India.
² Department of Biotechnology, Sree Sastha Institute of Engineering and Technology, Chembarambakkam, 600 123 Tamil Nadu, India. Electronic address: nmhariharan@gmail.com.

PMID: 35964556
DOI: 10.1016/j.oraloncology.2022.106063

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Squamous Cell* / diagnosis
Carcinoma, Squamous Cell* / genetics
Carcinoma, Squamous Cell* / therapy
Head and Neck Neoplasms* / diagnosis
Head and Neck Neoplasms* / genetics
Head and Neck Neoplasms* / therapy
Humans
MicroRNAs*
Squamous Cell Carcinoma of Head and Neck

Substances

MicroRNAs